Abstract
Purpose of Review
This is a review of the current understanding of the pathophysiology behind the development of daytime hypercapnia in a subset of obese patients. It provides an overview of the recent evidence to guide physicians in the diagnosis and treatment of patients with obesity hypoventilation syndrome (OHS).
Recent Findings
OHS results from a complex interplay between obesity-related changes in respiratory mechanics, sleep-disordered breathing, changes in central ventilatory drive, and neurohormonal changes. Diagnosis is important given the associated morbidity, but reliance on a single measurement of PaCO2 on the arterial blood gas has been questioned. Positive airway pressure (PAP) has been shown to improve gas exchange, sleep-disordered breathing, and symptoms in OHS, and is an effective therapy. More recent studies have not shown bilevel positive airway pressure or volume-targeted pressure support to be superior to CPAP in treating stable OHS, but NIV treatment studies are limited by variability in the settings used.
Summary
The development of daytime hypercapnia in a subset of obese patients is multifactorial. Phenotyping OHS patients can allow for individualization of therapies. Further long-term longitudinal studies exploring varying severities and clinical phenotypes of OHS are needed. There is also a need for additional studies to guide providers on the optimal PAP settings in OHS.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 2017;(288):1–8.
Organization WH. Obesity and overweight. 2018.
• Balachandran JS, Masa JF, Mokhlesi B. Obesity hypoventilation syndrome epidemiology and diagnosis. Sleep Med Clin. 2014;9(3):341–7 A review of OHS prevalence data.
Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007;131(6):1678–84.
Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med. 2004;116(1):1–7.
Sugerman HJ, Fairman RP, Baron PL, Kwentus JA. Gastric surgery for respiratory insufficiency of obesity. Chest. 1986;90(1):81–6.
Steier J, Lunt A, Hart N, Polkey MI, Moxham J. Observational study of the effect of obesity on lung volumes. Thorax. 2014;69(8):752–9.
Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol(1985). 2010;108(1):206–11.
Littleton SW. Impact of obesity on respiratory function. Respirology. 2012;17(1):43–9.
Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ. The total work of breathing in normal and obese men. J Clin Invest. 1964;43:728–39.
Lee MY, Lin CC, Shen SY, Chiu CH, Liaw SF. Work of breathing in eucapnic and hypercapnic sleep apnea syndrome. Respiration. 2009;77(2):146–53.
Kress JP, Pohlman AS, Alverdy J, Hall JB. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med. 1999;160(3):883–6.
Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care. 2010;55(10):1347–62 discussion 63-5.
Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med. 2011;183(3):292–8.
Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med. 1983;75(1):81–90.
Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV. Decreased hypoxic ventilatory drive in the obesity-hypoventilation syndrome. Am J Med. 1975;59(3):343–8.
Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 1996;348(9021):159–61.
Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax. 2002;57(1):75–6.
Shimura R, Tatsumi K, Nakamura A, Kasahara Y, Tanabe N, Takiguchi Y, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest. 2005;127(2):543–9.
Yee BJ, Cheung J, Phipps P, Banerjee D, Piper AJ, Grunstein RR. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration. 2006;73(2):209–12.
• Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM. CO(2) homeostasis during periodic breathing in obstructive sleep apnea. J Appl Physiol (1985). 2000;88(1):257–64 A small study exploring the kinetics of CO 2 during periodic breathing in OSA and interapnea ventilatory compensation for maintenance of CO 2 homeostasis.
Jaimchariyatam N, Dweik RA, Kaw R, Aboussouan LS. Polysomnographic determinants of nocturnal hypercapnia in patients with sleep apnea. J Clin Sleep Med. 2013;9(3):209–15.
Kittivoravitkul P, Kaw R, Hatipoglu U, Wang L, Aboussouan LS. Determinants of wake Pco2 and increases in wake Pco2 over time in patients with obstructive sleep apnea. Ann Am Thorac Soc. 2016;13(2):259–64.
Hlavac MC, Catcheside PG, McDonald R, Eckert DJ, Windler S, McEvoy RD. Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep. Sleep. 2006;29(5):624–31.
Norman RG, Goldring RM, Clain JM, Oppenheimer BW, Charney AN, Rapoport DM, et al. Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol (1985). 2006;100(5):1733–41.
Piper AJ, Grunstein RR. Big breathing: the complex interaction of obesity, hypoventilation, weight loss, and respiratory function. J Appl Physiol (1985). 2010;108(1):199–205.
Javaheri S, Simbartl LA. Respiratory determinants of diurnal hypercapnia in obesity hypoventilation syndrome. What does weight have to do with it? Ann Am Thorac Soc. 2014;11(6):945–50.
Kikuchi R, Tsuji T, Watanabe O, Yamaguchi K, Furukawa K, Nakamura H, et al. Hypercapnia accelerates adipogenesis: a novel role of high CO2 in exacerbating obesity. Am J Respir Cell Mol Biol. 2017;57(5):570–80.
Hart N, Mandal S, Manuel A, Mokhlesi B, Pepin JL, Piper A, et al. Rebuttal: ‘Obesity hypoventilation syndrome (OHS): does the current definition need revisiting?’. Thorax. 2014;69(10):955.
Hart N, Mandal S, Manuel A, Mokhlesi B, Pepin JL, Piper A, et al. Obesity hypoventilation syndrome: does the current definition need revisiting? Thorax. 2014;69(1):83–4.
Manuel ARG, Hart N, Stradling JR. Is a raised bicarbonate, without hypercapnia, part of the physiologic spectrum of obesity-related hypoventilation? Chest. 2015;147(2):362–8.
Sivam S, Yee B, Wong K, Wang D, Grunstein R, Piper A. Obesity hypoventilation syndrome: early detection of nocturnal-only hypercapnia in an obese population. J Clin Sleep Med. 2018;14(9):1477–84.
Sunwoo BY, Mokhlesi B. Obesity hypoventilation syndrome: will early detection and effective therapy improve long-term outcomes? J Clin Sleep Med. 2018;14(9):1455–7.
Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath. 2007;11(2):117–24.
Macavei VM, Spurling KJ, Loft J, Makker HK. Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med. 2013;9(9):879–84.
Bingol Z, Pihtili A, Cagatay P, Okumus G, Kiyan E. Clinical predictors of obesity hypoventilation syndrome in obese subjects with obstructive sleep apnea. Respir Care. 2015;60(5):666–72.
Basoglu OK, Tasbakan MS. Comparison of clinical characteristics in patients with obesity hypoventilation syndrome and obese obstructive sleep apnea syndrome: a case-control study. Clin Respir J. 2014;8(2):167–74.
Tulaimat A, Littleton S. Defining obesity hypoventilation syndrome. Thorax. 2014;69(5):491.
Monneret D. Bicarbonate or base excess in early obesity hypoventilation syndrome: a methodologic viewpoint. Chest. 2015;147(6):e231.
Monneret D, Devilliers C, Bonnefont-Rousselot D. Comparison of measured venous carbon dioxide and calculated arterial bicarbonates according to the PaCO2 and PaO2 cut-off values of obesity hypoventilation syndrome. Clin Chem Lab Med. 2015;53(12):e343–6.
Hollier CA, Maxwell LJ, Harmer AR, Menadue C, Piper AJ, Black DA, et al. Validity of arterialised-venous P CO2, pH and bicarbonate in obesity hypoventilation syndrome. Respir Physiol Neurobiol. 2013;188(2):165–71.
Budweiser S, Riedl SG, Jorres RA, Heinemann F, Pfeifer M. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med. 2007;261(4):375–83.
Carrillo A, Ferrer M, Gonzalez-Diaz G, Lopez-Martinez A, Llamas N, Alcazar M, et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(12):1279–85.
Castro-Anon O, Perez de Llano LA, De la Fuente Sanchez S, Golpe R, Mendez Marote L, Castro-Castro J, et al. Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PLoS One. 2015;10(2):e0117808.
Marik PE, Chen C. The clinical characteristics and hospital and post-hospital survival of patients with the obesity hypoventilation syndrome: analysis of a large cohort. Obes Sci Pract. 2016;2(1):40–7.
Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest. 2001;120(2):377–83.
Hida W. Quality of life in obesity hypoventilation syndrome. Sleep Breath. 2003;7(1):1–2.
Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest. 2001;120(2):369–76.
Alawami M, Mustafa A, Whyte K, Alkhater M, Bhikoo Z, Pemberton J. Echocardiographic and electrocardiographic findings in patients with obesity hypoventilation syndrome. Intern Med J. 2015;45(1):68–73.
Almeneessier AS, Nashwan SZ, Al-Shamiri MQ, Pandi-Perumal SR, BaHammam AS. The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study. J Thorac Dis. 2017;9(3):779–88.
Kauppert CA, Dvorak I, Kollert F, Heinemann F, Jorres RA, Pfeifer M, et al. Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med. 2013;107(12):2061–70.
Kaw R, Bhateja P, Paz YMH, Hernandez AV, Ramaswamy A, Deshpande A, et al. Postoperative complications in patients with unrecognized obesity hypoventilation syndrome undergoing elective noncardiac surgery. Chest. 2016;149(1):84–91.
BaHammam A. Acute ventilatory failure complicating obesity hypoventilation: update on a ‘critical care syndrome’. Curr Opin Pulm Med. 2010;16(6):543–51.
Perez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vazquez Caruncho M, Caballero Muinelos O, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest. 2005;128(2):587–94.
Bulbul Y, Ayik S, Ozlu T, Orem A. Frequency and predictors of obesity hypoventilation in hospitalized patients at a tertiary health care institution. Ann Thorac Med. 2014;9(2):87–91.
Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B. Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest. 2009;136(3):787–96.
BaHammam AS, Pandi-Perumal SR, Piper A, Bahammam SA, Almeneessier AS, Olaish AH, et al. Gender differences in patients with obesity hypoventilation syndrome. J Sleep Res. 2016;25(4):445–53.
Mandal S, Suh ES, Harding R, Vaughan-France A, Ramsay M, Connolly B, et al. Nutrition and exercise rehabilitation in obesity hypoventilation syndrome (NERO): a pilot randomised controlled trial. Thorax. 2018;73(1):62–9.
Colquitt J, Clegg A, Loveman E, Royle P, Sidhu MK. Surgery for morbid obesity. Cochrane Database Syst Rev 2005(4):CD003641.
DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356(21):2176–83.
Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.
Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(15):1492.
Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55(2 Suppl):615S–9S.
Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 2009;17(Suppl 1):S1–70.
Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.
Chanda A, Kwon JS, Wolff AJ, Manthous CA. Positive pressure for obesity hypoventilation syndrome. Pulm Med. 2012;2012:568690.
• Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax. 2008;63(5):395–401 An earlier prospective randomized study comparing bilevel positive airway pressure to CPAP in OHS.
• Howard ME, Piper AJ, Stevens B, Holland AE, Yee BJ, Dabscheck E, et al. A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax. 2017;72(5):437–44 A randomized controlled study of CPAP versus bilevel positive airway pressure for initial treatment of OHS.
• Contal O, Adler D, Borel JC, Espa F, Perrig S, Rodenstein D, et al. Impact of different backup respiratory rates on the efficacy of noninvasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest. 2013;143(1):37–46 A small study comparing the impact of backup rates on the efficacy of NIV in OHS.
• Janssens JP, Metzger M, Sforza E. Impact of volume targeting on efficacy of bi-level non-invasive ventilation and sleep in obesity-hypoventilation. Respir Med. 2009;103(2):165–72 A small randomized trial comparing bilevel positive airway pressure with and without volume target on overnight polysomnography with transcutaneous capnography.
• Storre JH, Seuthe B, Fiechter R, Milioglou S, Dreher M, Sorichter S, et al. Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest. 2006;130(3):815–21 A small randomized crossover trial comparing bilevel positive airway pressure with a bacakup rate to AVAPS in OHS.
•• Masa JF, Corral J, Alonso ML, Ordax E, Troncoso MF, Gonzalez M, et al. Efficacy of different treatment alternatives for obesity hypoventilation syndrome. Pickwick study. Am J Respir Crit Care Med. 2015;192(1):86–95 A randomized controlled trial comparing lifestyle modification, CPAP and NIV, in OHS with severe OSA.
•• Masa JF, Corral J, Caballero C, Barrot E, Teran-Santos J, Alonso-Alvarez ML, et al. Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea. Thorax. 2016;71(10):899–906 A randomized controlled trial comparing CPAP to lifestyle modification in OHS without severe OSA.
• Murphy PB, Davidson C, Hind MD, Simonds A, Williams AJ, Hopkinson NS, et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax. 2012;67(8):727–34 A randomized controlled trial comparing AVAPS to fixed level PS in OHS.
Duiverman ML. Noninvasive ventilation in stable hypercapnic COPD: what is the evidence? ERJ Open Res. 2018;4(2):00012–2018.
Baiamonte P, Mazzuca E, Gruttad’Auria CI, Castrogiovanni A, Marino C, Lo Nardo D, et al. Use of autobilevel ventilation in patients with obstructive sleep apnea: an observational study. J Sleep Res. 2018;27:e12680.
Orfanos S, Jaffuel D, Perrin C, Molinari N, Chanez P, Palot A. Switch of noninvasive ventilation (NIV) to continuous positive airway pressure (CPAP) in patients with obesity hypoventilation syndrome: a pilot study. BMC Pulm Med. 2017;17(1):50.
Bouloukaki I, Mermigkis C, Michelakis S, Moniaki V, Mauroudi E, Tzanakis N, et al. The association between adherence to positive airway pressure therapy and long-term outcomes in patients with obesity hypoventilation syndrome: a prospective observational study. J Clin Sleep Med. 2018;14(9):1539–50.
• Mokhlesi B, Tulaimat A, Evans AT, Wang Y, Itani AA, Hassaballa HA, et al. Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med. 2006;2(1):57–62 An observational study showing clear association between PAP adherence and improvement in hypercapnia in OSA.
Borel JC, Tamisier R, Gonzalez-Bermejo J, Baguet JP, Monneret D, Arnol N, et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012;141(3):692–702.
Carter JR, Fonkoue IT, Grimaldi D, Emami L, Gozal D, Sullivan CE, et al. Positive airway pressure improves nocturnal beat-to-beat blood pressure surges in obesity hypoventilation syndrome with obstructive sleep apnea. Am J Phys Regul Integr Comp Phys. 2016;310(7):R602–11.
Corral J, Mogollon MV, Sanchez-Quiroga MA, Gomez de Terreros J, Romero A, Caballero C, et al. Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome. Thorax. 2018;73(4):361–8.
Onofri A, Patout M, Kaltsakas G, Lhuillier E, Mushemi-Blake S, Arbane G, et al. Neural respiratory drive and cardiac function in patients with obesity hypoventilation syndrome following initiation of non-invasive ventilation. J Thorac Dis. 2018;10(Suppl 1):S135–S43.
Castellana G, Dragonieri S, Marra L, Quaranta V, Carratu P, Ranieri T, et al. Nocturnal hypoventilation may have a protective effect for ischemic heart disease in obesity hypoventilation syndrome. Rejuvenation Res. 2018;22(1):13–9.
Masa JF, Corral J, Romero A, Caballero C, Teran-Santos J, Alonso-Alvarez ML, et al. Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome. Chest. 2016;150(1):68–79.
Hollier CA, Harmer AR, Maxwell LJ, Menadue C, Willson GN, Unger G, et al. Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax. 2014;69(4):346–53.
Wijesinghe M, Williams M, Perrin K, Weatherall M, Beasley R. The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. Chest. 2011;139(5):1018–24.
• Masa JF, Corral J, Romero A, Caballero C, Teran-Santos J, Alonso-Alvarez ML, et al. The effect of supplemental oxygen in obesity hypoventilation syndrome. J Clin Sleep Med. 2016;12(10):1379–88 A post hoc analysis of the Pickwick study assessing supplemental oxygen therapy in OHS.
Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the “Pickwickian syndrome”. Chest. 1986;89(5):627–35.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Bernie Sunwoo declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Sleeping and Breathing
Rights and permissions
About this article
Cite this article
Sunwoo, B.Y. Obesity Hypoventilation: Pathophysiology, Diagnosis, and Treatment. Curr Pulmonol Rep 8, 31–39 (2019). https://doi.org/10.1007/s13665-019-0223-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13665-019-0223-x